Clinicopathological significance of p53, hypoxia-inducible factor 1α, and vascular endothelial growth factor expression in colorectal cancer

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 4163-4168

  Kwon, Hyuk Chan ^a   Kim, Sung Hyun ^a   Oh, Sung Yong ^a   Lee, Suee ^a   Kwon, Kyung A ^a   Choi, Hong Jo ^a   Park, Ki Jae ^a   Kim, Hyo Jin ^a   Roh, Mee Sook ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Colorectal carcinoma; Hypoxia inducible factor 1 alpha; p53; Vascular endothelial growth factor

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; COLORECTAL CARCINOMA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CANCER; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 78650232336     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, Park EC, Ahn YO, Hwang IK, Lee DH, Choi JS, Kim WC, Lee TY, Yoo CI, Bae JM, Kim ON, Chung W, Kong IS and Lee JS: Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat 41: 122-131, 2009.
3. Zafirellis K, Agrogiannis G, Zachaki A, Gravani K, Karameris A and Kombouras C: Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. J Surg Res 147: 99-107, 2008.
4. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M and Chayama K: Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105: 176-181, 2003.
5. Furlan D, Sahnane N, Carnevali I, Cerutti R, Uccella S, Bertolini V, Chiaravalli AM and Capella C: Up-regulation and stabilization of HIF-1alpha in colorectal carcinomas. Surg Oncol 16(Suppl 1): S25-27, 2007.
6. Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, Ueda S, Kinugasa S, Tachibana M and Nagasue N: Prognostic impact of hypoxia-inducible factors 1 alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res 10: 8554-8560, 2004.
7. Dang CV and Semenza GL: Oncogenic alterations of metabolism. Trends Biochem Sci 24: 68-72, 1999.
8. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
9. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
10. Chai CY, Chen WT, Hung WC, Kang WY, Huang YC, Su YC and Yang CH: Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol 61: 658-664, 2008.
11. Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, Kovach JS and Thibodeau SN: Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 52: 1974-1980, 1992.
12. Dameron KM, Volpert OV, Tainsky MA and Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584, 1994.
13. Kieser A, Weich HA, Brandner G, Marme D and Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994.
14. Sarioglu S, Sokmen S, Terzi C, Ozer E, Fuzun M and Kupelioglu A: Relationship of angiogenesis and p53 protein expression in colorectal carcinomas. Colorectal Dis 3: 38-41, 2001.
15. Wincewicz A, Sulkowska M, Koda M and Sulkowski S: Cumulative expression of HIF-1-alpha, BAX, BCL-xL and P53 in human colorectal cancer. Pathology 39: 334-338, 2007.
16. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
17. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578, 1999.
18. Ruan K, Song G and Ouyang G: Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 107: 1053-1062, 2009.
19. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P and Semenza GL: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63: 1138-1143, 2003.
20. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996.
21. Poon RT, Fan ST and Wong J: Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19: 1207-1225, 2001.
22. Zheng S, Han MY, Xiao ZX, Peng JP and Dong Q: Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol 9: 1227-1230, 2003.
23. Blagosklonny MV, Giannakakou P, Wojtowicz M, Romanova LY, Ain KB, Bates SE and Fojo T: Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells. J Clin Endocrinol Metab 83: 2516-2522, 1998.
24. Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, Fang B, Lee JJ and Roth JA: Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 58: 2288-2292, 1998.
25. Takahashi Y, Bucana CD, Cleary KR and Ellis LM: p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 79: 34-38, 1998. (Pubitemid 28157723)
26. Diaz R, Pena C, Silva J, Lorenzo Y, Garcia V, Garcia JM, Sanchez A, Espinosa P, Yuste R, Bonilla F and Dominguez G: p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b down-regulation as a marker of poor prognosis. Int J Cancer 123: 1060-1067, 2008.
27. Georgiou L, Minopoulos G, Lirantzopoulos N, Fiska-Demetriou A, Maltezos E and Sivridis E: Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage. J Surg Res 131: 118-123, 2006.
28. Chen D, Li M, Luo J and Gu W: Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 278: 13595-13598, 2003.
29. Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, Srivastava S and Grizzle WE: Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 74: 346-358, 1997.